GOSS Gossamer Bio, Inc.

NEUTRAL Impact: 3/10 Institutional Cluster
Horizon weeks Processed 2d 3h ago
Institutional cluster: 4 buyers, 2 sellers (mixed)

Executive Summary

Four mega-passive institutional investors (State Street, Invesco, UBS, BofA) significantly increased their GOSS holdings in Q3 2025, adding $22.2M in net new positions, while two sellers (Fidelity, Morgan Stanley) trimmed $2.2M. The buying is dominated by passive/index funds, likely reflecting index rebalancing or systematic allocation rather than a fundamental thesis, and the cluster's mixed net conviction and historical underperformance on GOSS calls (0% win rate at T+20) suggest limited trading signal.

Key Financial Metrics

Direction
accumulating
Buy Value
$26.0M
Sell Value
$12.2M
Net Flow
$20.0M

Institutional Positions

Net institutional flow: $20.0M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
State Street ADD +56.5% $10.2M $7.2M
Invesco ADD +47.2% $926.0K $632.0K
UBS DOUBLED +785.7% $7.3M $6.9M
BofA DOUBLED +4196.2% $7.6M $7.5M

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
Fidelity TRIM -44.2% $9.0M $1.7M
Morgan Stanley TRIM -30.8% $1.0M $483.0K

Actionable Insight

The cluster is entirely passive/index-driven with no active manager conviction — treat as index rebalancing noise, not a fundamental signal. Monitor for any active fund 13F filings or insider buying to confirm a real thesis shift. Given GOSS's $37M market cap, the $20M net inflow is large relative to float but likely mechanical.

Key Facts

  • 4 buyers added $22.2M net; 2 sellers reduced $2.2M; aggregate net buying of $20.0M
  • All 6 institutions are mega-passive (index/rebalancing) — no active managers or hedge funds involved
  • UBS and BofA both DOUBLED positions, with BofA increasing shares by 4,196% (67K → 2.88M shares)
  • Fidelity trimmed 44.2% of its position (7.32M → 4.09M shares) but value rose $1.7M due to stock appreciation
  • Historical GOSS reports show 0% win rate at T+20 across 3 settled calls, with avg alpha -25.16% vs SPY

Financial Impact

4 passive institutions accumulated $22.2M in new GOSS positions while 2 passive institutions reduced holdings by $2.2M, for a net institutional inflow of $20.0M in Q3 2025

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound since quarter-end
  • Passive flows can reverse on next rebalance date with no fundamental catalyst
  • Historical GOSS reports have 0% win rate at T+20 — prior cluster signals on this ticker have been unreliable

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
57% bullish (14 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-GOSS-2025-Q3
5 reports for GOSS
Performance horizon
Filters
Rows
Reports for GOSS — sortable, filterable
Type Now
Jun 11, 2026
2d ago
Institutional Cluster
NEUTRAL ★ 3/10
$0.1554 awaiting T+1awaiting T+1
Jun 2, 2026
11d ago
8-K
NEUTRAL ★ 5/10
$0.2000 $0.1880▼ −6.00%▼ −5.31%
May 18, 2026
26d ago
DEFA14A
MIXED ★ 7/10
$0.1930 $0.1990▲ +3.11%▲ +3.76%
Apr 24, 2026
7w ago
DEFA14A
NEUTRAL ★ 2/10
$0.3490 $0.3450▼ −1.15%▼ −0.66%
Mar 19, 2026
12w ago
EFFECT
NEUTRAL ★ 4/10
$0.4520 $0.4220▼ −6.64%▼ −4.90%
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (45h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access